S

Stenocare A/S
CSE:STENO

Watchlist Manager
Stenocare A/S
CSE:STENO
Watchlist
Price: 1.625 DKK 1.56% Market Closed
Market Cap: 70.5m DKK

Stenocare A/S
Free Cash Flow

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Stenocare A/S
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
S
Stenocare A/S
CSE:STENO
Free Cash Flow
-kr7.2m
CAGR 3-Years
24%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Novo Nordisk A/S
CSE:NOVO B
Free Cash Flow
kr61B
CAGR 3-Years
2%
CAGR 5-Years
6%
CAGR 10-Years
7%
H Lundbeck A/S
CSE:HLUN A
Free Cash Flow
kr2.8B
CAGR 3-Years
18%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ALK-Abello A/S
CSE:ALK B
Free Cash Flow
kr218m
CAGR 3-Years
14%
CAGR 5-Years
20%
CAGR 10-Years
N/A
No Stocks Found

Stenocare A/S
Glance View

Market Cap
70.5m DKK
Industry
Pharmaceuticals

Stenocare A/S engages in the cultivation, manufacture, and distribution of medical cannabis products. The Company’s business model has two divisions: Import and wholesale of finished medical cannabis products for Danish patients, as well as Operate own cultivation- and production facility in Denmark to produce finished cannabis products for Danish and European patients. The firm distributes its products through pharmacies and hospitals. Stenocare's head office is located in Randers, Denmark.

STENO Intrinsic Value
0.396 DKK
Overvaluation 76%
Intrinsic Value
Price
S

See Also

What is Stenocare A/S's Free Cash Flow?
Free Cash Flow
-7.2m DKK

Based on the financial report for Dec 31, 2024, Stenocare A/S's Free Cash Flow amounts to -7.2m DKK.

What is Stenocare A/S's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
8%

Over the last year, the Free Cash Flow growth was 30%. The average annual Free Cash Flow growth rates for Stenocare A/S have been 24% over the past three years , 8% over the past five years .

Back to Top